| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Chemokine signaling pathway |
8 genes: GNAI2, GNG7, JAK3, CCL14, CX3CL1, CXCR5, STAT5B, ELMO1
|
0.0008347 |
| MAPK signaling pathway |
8 genes: MAPK14, DUSP8, MAP3K3, NFATC4, RPS6KA2, SRF, MAP3K14, MAPK8IP1
|
0.007145 |
| Axon guidance |
5 genes: SEMA6B, DPYSL2, NTNG1, GNAI2, NFATC4
|
0.01165 |
| Cell adhesion molecules .CAMs. |
5 genes: NFASC, HLA-DOB, CADM3, CNTN2, CD6
|
0.01394 |
| Melanogenesis |
4 genes: GNAI2, GNAO1, WNT9A, TCF7L1
|
0.02122 |
| Inositol phosphate metabolism |
3 genes: PIP5K1C, INPP5B, ITPK1
|
0.0215 |
| Jak.STAT signaling pathway |
5 genes: CTF1, CLCF1, JAK3, OSM, STAT5B
|
0.02314 |
| T cell receptor signaling pathway |
4 genes: MAPK14, NFATC4, ZAP70, MAP3K14
|
0.02635 |
| PI3K AKT signaling pathway |
8 genes: CSF1, NGFR, OSM, JAK3, LAMC3, ITGA5, GNG7, PPP2R5B
|
0.03091 |
| Pentose phosphate pathway |
2 genes: PFKM, H6PD
|
0.03186 |
| Galactose metabolism |
2 genes: GCK, PFKM
|
0.03186 |
| PPAR signaling pathway |
3 genes: ILK, SLC27A1, PLTP
|
0.0365 |
| Neurotrophin signaling pathway |
4 genes: MAPK14, MAP3K3, NGFR, RPS6KA2
|
0.04375 |
| Osteoclast differentiation |
4 genes: OSCAR, MAPK14, CSF1, MAP3K14
|
0.04481 |
| Phosphatidylinositol signaling system |
3 genes: PIP5K1C, INPP5B, ITPK1
|
0.0478 |